BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 20825416)

  • 1. Global histone acetylation levels: prognostic relevance in patients with renal cell carcinoma.
    Mosashvilli D; Kahl P; Mertens C; Holzapfel S; Rogenhofer S; Hauser S; Büttner R; Von Ruecker A; Müller SC; Ellinger J
    Cancer Sci; 2010 Dec; 101(12):2664-9. PubMed ID: 20825416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global histone H3 lysine 27 (H3K27) methylation levels and their prognostic relevance in renal cell carcinoma.
    Rogenhofer S; Kahl P; Mertens C; Hauser S; Hartmann W; Büttner R; Müller SC; von Ruecker A; Ellinger J
    BJU Int; 2012 Feb; 109(3):459-65. PubMed ID: 21810159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic relevance of global histone H3 lysine 4 (H3K4) methylation in renal cell carcinoma.
    Ellinger J; Kahl P; Mertens C; Rogenhofer S; Hauser S; Hartmann W; Bastian PJ; Büttner R; Müller SC; von Ruecker A
    Int J Cancer; 2010 Nov; 127(10):2360-6. PubMed ID: 20162570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of global levels of histone modifications with recurrence-free survival in stage IIB and III esophageal squamous cell carcinomas.
    I H; Ko E; Kim Y; Cho EY; Han J; Park J; Kim K; Kim DH; Shim YM
    Cancer Epidemiol Biomarkers Prev; 2010 Feb; 19(2):566-73. PubMed ID: 20142251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased levels of histone H3K9me1 indicate poor prognosis in patients with renal cell carcinoma.
    Rogenhofer S; Kahl P; Holzapfel S; VON Ruecker A; Mueller SC; Ellinger J
    Anticancer Res; 2012 Mar; 32(3):879-86. PubMed ID: 22399607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The global histone modification pattern correlates with cancer recurrence and overall survival in gastric adenocarcinoma.
    Park YS; Jin MY; Kim YJ; Yook JH; Kim BS; Jang SJ
    Ann Surg Oncol; 2008 Jul; 15(7):1968-76. PubMed ID: 18470569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of p53 as a prognostic marker in histologic subtypes of renal cell carcinoma: a systematic analysis of primary and metastatic tumor tissue.
    Zigeuner R; Ratschek M; Rehak P; Schips L; Langner C
    Urology; 2004 Apr; 63(4):651-5. PubMed ID: 15072872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global histone modifications predict prognosis of resected non small-cell lung cancer.
    Barlési F; Giaccone G; Gallegos-Ruiz MI; Loundou A; Span SW; Lefesvre P; Kruyt FA; Rodriguez JA
    J Clin Oncol; 2007 Oct; 25(28):4358-64. PubMed ID: 17906200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global levels of histone modifications predict prostate cancer recurrence.
    Ellinger J; Kahl P; von der Gathen J; Rogenhofer S; Heukamp LC; Gütgemann I; Walter B; Hofstädter F; Büttner R; Müller SC; Bastian PJ; von Ruecker A
    Prostate; 2010 Jan; 70(1):61-9. PubMed ID: 19739128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limited prognostic value of tumor necrosis in patients with renal cell carcinoma.
    Isbarn H; Patard JJ; Lughezzani G; Rioux-Leclercq N; Crépel M; Cindolo L; de la Taille A; Zini L; Villers A; Shariat SF; Bertini R; Karakiewicz PI
    Urology; 2010 Jun; 75(6):1378-84. PubMed ID: 19781745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromophobe renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 145 cases.
    Amin MB; Paner GP; Alvarado-Cabrero I; Young AN; Stricker HJ; Lyles RH; Moch H
    Am J Surg Pathol; 2008 Dec; 32(12):1822-34. PubMed ID: 18813125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global histone modification pattern associated with recurrence and disease-free survival in non-small cell lung cancer patients.
    Song JS; Kim YS; Kim DK; Park SI; Jang SJ
    Pathol Int; 2012 Mar; 62(3):182-90. PubMed ID: 22360506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do DNA-methylation and histone acetylation play a role in clear cell renal carcinoma? Analysis of radical nephrectomy specimens in a long-term follow-up.
    Minardi D; Lucarini G; Filosa A; Zizzi A; Milanese G; Polito M; Polito M; Di Primio R; Montironi R; Muzzonigro G
    Int J Immunopathol Pharmacol; 2011; 24(1):149-58. PubMed ID: 21496397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histological subtyping and nuclear grading of renal cell carcinoma and their implications for survival: a retrospective nation-wide study of 629 patients.
    Gudbjartsson T; Hardarson S; Petursdottir V; Thoroddsen A; Magnusson J; Einarsson GV
    Eur Urol; 2005 Oct; 48(4):593-600. PubMed ID: 15964127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global histone modification pattern predicts poor prognosis in organic hyperinsulinism.
    Raffel A; Krausch M; Roushan K; Anlauf M; Henopp T; Hafner D; Lehwald N; Kröpil F; Schott M; Eisenberger CF; Knoefel WT; Stoecklein NH
    Horm Metab Res; 2011 Nov; 43(12):858-64. PubMed ID: 22105476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation of microvessel density with microvascular invasion, metastasis and prognosis in renal cell carcinoma.
    Yildiz E; Ayan S; Goze F; Gokce G; Gultekin EY
    BJU Int; 2008 Mar; 101(6):758-64. PubMed ID: 18070177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The global histone modification pattern correlates with overall survival in metachronous liver metastasis of colorectal cancer.
    Tamagawa H; Oshima T; Shiozawa M; Morinaga S; Nakamura Y; Yoshihara M; Sakuma Y; Kameda Y; Akaike M; Masuda M; Imada T; Miyagi Y
    Oncol Rep; 2012 Mar; 27(3):637-42. PubMed ID: 22076537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased acetylation of histone H3 in renal cell carcinoma: a potential target of histone deacetylase inhibitors.
    Kanao K; Mikami S; Mizuno R; Shinojima T; Murai M; Oya M
    J Urol; 2008 Sep; 180(3):1131-6. PubMed ID: 18639283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic relevance of capsular involvement and collecting system invasion in stage I and II renal cell carcinoma.
    Klatte T; Chung J; Leppert JT; Lam JS; Pantuck AJ; Figlin RA; Belldegrun AS
    BJU Int; 2007 Apr; 99(4):821-4. PubMed ID: 17244281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of renal vein and inferior vena cava involvement in renal cell carcinoma.
    Wagner B; Patard JJ; Méjean A; Bensalah K; Verhoest G; Zigeuner R; Ficarra V; Tostain J; Mulders P; Chautard D; Descotes JL; de la Taille A; Salomon L; Prayer-Galetti T; Cindolo L; Valéri A; Meyer N; Jacqmin D; Lang H
    Eur Urol; 2009 Feb; 55(2):452-9. PubMed ID: 18692951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.